 |
|
The Epidemiology of Panic Attacks, Panic Disorder, and Agoraphobia in the National Comorbidity Survey Replication
Ronald C. Kessler, PhD;
Wai Tat Chiu, AM;
Robert Jin, MA;
Ayelet Meron Ruscio, PhD;
Katherine Shear, MD;
Ellen E. Walters, MS
Arch Gen Psychiatry. 2006;63:415-424.
Context Only limited information exists about the epidemiology of DSM-IV panic attacks (PAs) and panic disorder (PD).
Objective To present nationally representative data about the epidemiology of PAs and PD with or without agoraphobia (AG) on the basis of the US National Comorbidity Survey Replication findings.
Design and Setting Nationally representative face-to-face household survey conducted using the fully structured World Health Organization Composite International Diagnostic Interview.
Participants English-speaking respondents (N=9282) 18 years or older.
Main Outcome Measures Respondents who met DSM-IV lifetime criteria for PAs and PD with and without AG.
Results Lifetime prevalence estimates are 22.7% for isolated panic without AG (PA only), 0.8% for PA with AG without PD (PA-AG), 3.7% for PD without AG (PD only), and 1.1% for PD with AG (PD-AG). Persistence, lifetime number of attacks, and number of years with attacks increase monotonically across these 4 subgroups. All 4 subgroups are significantly comorbid with other lifetime DSM-IV disorders, with the highest odds for PD-AG and the lowest for PA only. Scores on the Panic Disorder Severity Scale are also highest for PD-AG (86.3% moderate or severe) and lowest for PA only (6.7% moderate or severe). Agoraphobia is associated with substantial severity, impairment, and comorbidity. Lifetime treatment is high (from 96.1% for PD-AG to 61.1% for PA only), but 12-month treatment meeting published treatment guidelines is low (from 54.9% for PD-AG to 18.2% for PA only).
Conclusion Although the major societal burden of panic is caused by PD and PA-AG, isolated PAs also have high prevalence and meaningful role impairment.
Author Affiliations: Department of Health Care Policy, Harvard Medical School, Boston, Mass (Drs Kessler and Ruscio, Messrs Chiu and Jin, and Ms Walters); and the Western Psychiatric Institute and Clinic, Pittsburgh, Pa (Dr Shear).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Psychiatric Treatment Received by Primary Care Patients With Panic Disorder With and Without Agoraphobia
Marcks et al.
Psychiatr. Serv. 2009;60:823-830.
ABSTRACT
| FULL TEXT
Use of Psychoactive Substances and Health Care in Response to Anxiety and Depressive Disorders
Encrenaz et al.
Psychiatr. Serv. 2009;60:351-357.
ABSTRACT
| FULL TEXT
Altered Cerebral {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptor Binding in Panic Disorder Determined by [11C]Flumazenil Positron Emission Tomography
Hasler et al.
Arch Gen Psychiatry 2008;65:1166-1175.
ABSTRACT
| FULL TEXT
Patient Management Exercise for Panic Disorder
Levine and Albucher
Focus 2008;6:451-458.
ABSTRACT
| FULL TEXT
Bibliography: Panic and Social Anxiety Disorder
Focus 2008;6:459-461.
FULL TEXT
Abstracts: Panic and Social Anxiety Disorder
Focus 2008;6:462-466.
FULL TEXT
Using Computerized Adaptive Testing to Reduce the Burden of Mental Health Assessment
Gibbons et al.
Psychiatr. Serv. 2008;59:361-368.
ABSTRACT
| FULL TEXT
L'identification et traitement du trouble panique avec ou sans agoraphobie: Mise a jour
Foldes-Busque et al.
cfp 2007;53:1686-1693.
ABSTRACT
| FULL TEXT
Panic Attacks and Risk of Incident Cardiovascular Events Among Postmenopausal Women in the Women's Health Initiative Observational Study
Smoller et al.
Arch Gen Psychiatry 2007;64:1153-1160.
ABSTRACT
| FULL TEXT
|
